当前位置: 首页 > 期刊 > 《世界中医药》 > 201810
编号:13584529
芪参益气滴丸治疗冠心病介入术后合并高血压患者的预后研究(4)
http://www.100md.com 2018年5月15日 《世界中医药》 201810
     [10]Gu JY,Yuan G,Zhu YH,et al.Computational pharmacological studies on cardiovascular disease by Qishen Yiqi Diwan[J].Sci China Ser BChem,2009,52(11):1871.

    [11]Ge YB,Mao JY.Study on the distribution characteristics of the TCM syndromes of 7512 coronary artery disease patients[J].Shandong J Tradit Chin Med,2011,4:227.

    [12]王靜,刘桂华,王爱玲.芪参益气滴丸对急性心肌梗死大鼠心肌细胞凋亡及心功能的影响[J].中国老年学杂志,2013,33(12):28472848.

    [13]Wang Y,Wang J,Guo L,et al.Antiplatelet effects of qishen yiqi dropping pill in platelets aggregation in hyperlipidemic rabbits[J].Evid Based Complement Alternat Med,2012,2012:205451.

    [14]Zhang L,Wang Y,Yu L,et al.QISHENYIQI accelerates angiogenesis after myocardial infarction in rats[J].Int J Cardiol,2010,143(1):105109.

    [15]朱明丹,杜武勋,刘长玉,等.芪参益气滴丸对AMI大鼠心肌炎性反应因子影响的动态观察[J].时珍国医国药,2013,24(1):2225.

    [16]许颖智,张军平,庞树朝,等.芪参益气滴丸干预心肌梗死大鼠免疫与炎性反应的机制[J].中国医学前沿杂志(连续型电子期刊),2012,4(8):5155.

    [17]骆小梅,徐洁,王贵鹏.芪参益气滴丸治疗冠心病心绞痛的临床疗效观察[J].实用心脑肺血管病杂志,2015,1(10):151153.

    [18]刘亚洋,李鹤,朱源生.芪参益气滴丸对冠心病慢性心力衰竭患者心功能、免疫功能及micro RNA155水平的影响[J].中西医结合心脑血管病杂志,2017,15(11):13421344.

    [19]Lee MG,Jeong MH,Lee KH,et al.Prognostic impact of diabetes mellitus and hypertension for midterm outcome of patients with acute myocardial infarction who underwent percutaneous coronary intervention[J].J Cardiol,2012,60(4):257263.

    (2018-04-25收稿责任编辑:王明), 百拇医药(谷丰 杨巧宁 白瑞娜)
上一页1 2 3 4